调研速递|赛隆药业接受线上投资者调研，聚焦业务布局与发展规划

Group 1 - The company held an online investor interaction session on September 19, 2025, where key executives addressed various investor inquiries regarding restricted stock release, business layout, asset acquisitions, shareholder numbers, and stock price stability [1][2][3] - Regarding the restricted stock release, the company stated that according to the Shenzhen Stock Exchange's regulations, there are restrictions on the transfer of shares by directors and senior management during their term and for six months after [1] - The company has launched its Xinjiang factory and strategically entered the AI server business, achieving revenue of 53.98 million yuan from AI server operations during the reporting period, aiming to become a provider of integrated solutions for high-performance AI servers [1] Group 2 - The company currently has no plans for issuing shares to purchase assets, major asset restructuring, or acquisitions, and will disclose any future developments in a timely manner [2] - To ensure fair information disclosure, the company will report shareholder numbers in its regular reports, and it is focused on improving its main business and creating new profit growth points to address stock price declines [3] - The board of directors has approved a proposal to amend the company's articles of association to add the position of vice chairman, which still requires shareholder meeting approval [3]